Ipilimumab,Nivolumab
BMS
['colibri', 'nivo', 'gyn', 'pioneer', 'potentia,(-potential)']
 is always a pioneer in gyn onc research. timing of i/o treatment relative to ccrt matters in lacc. colibri study provides evidence that neoadjuvant nivo-ipi increased the inflammatory milieau potentiating efficacy. #asco23. rich translational program to follow. 
Ασυνάρτητος και ημιτελής. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.